Cadre’s fourth quarter was marked by revenue and margin declines, missing Wall Street expectations and prompting a sharp negative market reaction. Management attributed underperformance to timing shifts in large defense and nuclear contracts, distribution softness, and a temporary slowdown in certain nuclear projects following regulatory changes. CFO Blaine Browers acknowledged the impact of these delays, while CEO Warren Kanders emphasized ongoing demand for core public safety and defense offerings. The company also cited ongoing integration of recent acquisitions and highlighted a growing order backlog as a positive sign.
Is now the time to buy CDRE? Find out in our full research report (it’s free for active Edge members).
Cadre (CDRE) Q4 CY2025 Highlights:
- Revenue: $167.2 million vs analyst estimates of $184.3 million (5% year-on-year decline, 9.3% miss)
- Adjusted EPS: $0.29 vs analyst expectations of $0.47 (37.4% miss)
- Adjusted EBITDA: $34.4 million vs analyst estimates of $37.29 million (20.6% margin, 7.7% miss)
- EBITDA guidance for the upcoming financial year 2026 is $138.5 million at the midpoint, below analyst estimates of $141.5 million
- Operating Margin: 12.2%, down from 16.7% in the same quarter last year
- Market Capitalization: $1.40 billion
While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
Our Top 5 Analyst Questions From Cadre’s Q4 Earnings Call
-
Lawrence Scott Solow (CJS Securities) asked if delayed defense and nuclear orders would create a domino effect or eventually catch up. President Brad Williams explained that most large opportunities have strong visibility and are in backlog, noting, "we have closed a lot of those opportunities."
-
Eegan McDermott (Jefferies) questioned confidence in remaining delayed contracts not being lost. Williams responded with "100% confidence" that delays are timing-related, not cancellations, due to direct customer communication and contract status.
-
Matthew Butler Koranda (Roth Capital) probed the revenue contribution and cadence of TIER Tactical post-acquisition. CFO Blaine Browers stated guidance assumes a conservative approach, with TIER expected to contribute high-margin revenue, mostly realized later in the year.
-
Jeff Van Sinderen (B. Riley Securities) inquired about the sustainability of nuclear segment headwinds and the outlook for Med-Eng’s blast seat contract. Williams outlined that the shift in nuclear priorities is likely temporary and described the Med-Eng seat as a highly specialized, proven solution for military vehicles.
-
Mark Eric Smith (Lake Street) asked about synergies from the TIER acquisition and their inclusion in guidance. Williams clarified that no cross-business synergies are included in the current outlook, as initial efforts focus on integration and launching joint projects.
Catalysts in Upcoming Quarters
Looking forward, the StockStory team is monitoring (1) the pace at which delayed defense and nuclear contracts convert to revenue, (2) the ramp-up and integration of TIER Tactical’s products and customer relationships across Cadre’s business units, and (3) signs of recovery in nuclear safety product demand as federal policy priorities evolve. M&A execution and margin stabilization will also be critical signposts for future results.
Cadre currently trades at $33.30, down from $40.69 just before the earnings. Is there an opportunity in the stock?Find out in our full research report (it’s free).
The Best Stocks for High-Quality Investors
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
